Guided Therapeutics signs new China distribution deal for LuViva device
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation
July 14, 2026 9:00 AM EDTPEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon... More
